NCT05646654

Brief Summary

The aim of this study is to compare the effectiveness of ESPB versus ISB in anesthesia for shoulder arthroscopy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

December 15, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2023

Completed
Last Updated

April 19, 2023

Status Verified

April 1, 2023

Enrollment Period

5 months

First QC Date

December 4, 2022

Last Update Submit

April 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intraoperative fentanyl consumption

    Fntanyl will be administered 1 µg/kg IV increments.

    30 minutes

Secondary Outcomes (3)

  • Postoperative pain

    24 hours postoperative

  • Rescue analgesia in the form of IV meperidine (0.5 mg/kg) boluses if NRS >3. Time to the 1st rescue analgesic request will be recorded

    24 hours postoperative

  • Total amount of rescue analgesic

    24 hours postoperative

Study Arms (2)

Erector spinae plane block group

ACTIVE COMPARATOR

3ml lidocaine 2% will be used to anesthetize the skin. Using a 20-gauge block needle put in-plane in a cephalad-to-caudad orientation to position the tip into the fascial plane on the deep (anterior) side of the erector spinae muscle, 20 ml bupivacaine 0.5% will be injected.

Procedure: Erector spinae plane block

Interscalene group

ACTIVE COMPARATOR

Using a lateral-to-medial approach, the 25-gauge needle will be inserted into the middle scalene muscle, advanced, and placed immediately lateral to the nerve roots. the needle will be visualize using an ultrasound beam to avoid intraneural and intravascular injections. After confirming negative blood aspiration, we will inject 15 mL of 0.5% bupivacaine around the nerve roots

Procedure: Interscalene brachial plexus block

Interventions

Using a 20-gauge block needle put in-plane in a cephalad-to-caudad orientation to position the tip into the fascial plane on the deep (anterior) side of the erector spinae muscle, 20 ml bupivacaine 0.5% will be injected

Erector spinae plane block group

Using a lateral-to-medial approach, the 25-gauge needle will be inserted into the middle scalene muscle, advanced, and placed immediately lateral to the nerve roots. the needle will be visualize using an ultrasound beam to avoid intraneural and intravascular injections. After confirming negative blood aspiration, we will inject 15 mL of 0.5% bupivacaine around the nerve roots

Interscalene group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Body Mass Index \< 40 kg/m2
  • American Society of Anesthesiologists (ASA) physical status I-II
  • scheduled for elective shoulder arthroscopy

You may not qualify if:

  • Known allergy to local anesthetics
  • Allergy to all opioid medications
  • Diagnostic shoulder arthroscopic procedures
  • Patients with chronic opioids
  • Patients who converted to general anesthesia use and coagulopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Islam Morsy

Tanta, El-Gharbia, 31527, Egypt

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesia, Surgical Intensive Care and Pain Medicine

Study Record Dates

First Submitted

December 4, 2022

First Posted

December 12, 2022

Study Start

December 15, 2022

Primary Completion

May 15, 2023

Study Completion

May 15, 2023

Last Updated

April 19, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

The data will be available upon reasonable request from the principal investigator

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
For one year after completion of the study

Locations